236 related articles for article (PubMed ID: 23098562)
41. Rod differentiation factor NRL activates the expression of nuclear receptor NR2E3 to suppress the development of cone photoreceptors.
Oh EC; Cheng H; Hao H; Jia L; Khan NW; Swaroop A
Brain Res; 2008 Oct; 1236():16-29. PubMed ID: 18294621
[TBL] [Abstract][Full Text] [Related]
42. The rod photoreceptor-specific nuclear receptor Nr2e3 represses transcription of multiple cone-specific genes.
Chen J; Rattner A; Nathans J
J Neurosci; 2005 Jan; 25(1):118-29. PubMed ID: 15634773
[TBL] [Abstract][Full Text] [Related]
43. Nr2e3-directed transcriptional regulation of genes involved in photoreceptor development and cell-type specific phototransduction.
Haider NB; Mollema N; Gaule M; Yuan Y; Sachs AJ; Nystuen AM; Naggert JK; Nishina PM
Exp Eye Res; 2009 Sep; 89(3):365-72. PubMed ID: 19379737
[TBL] [Abstract][Full Text] [Related]
44. HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin.
Muretta JM; Rajasekaran D; Blat Y; Little S; Myers M; Nair C; Burdekin B; Yuen SL; Jimenez N; Guhathakurta P; Wilson A; Thompson AR; Surti N; Connors D; Chase P; Harden D; Barbieri CM; Adam L; Thomas DD
SLAS Discov; 2023 Jul; 28(5):223-232. PubMed ID: 37307989
[TBL] [Abstract][Full Text] [Related]
45. Identification of potent agonists of photoreceptor-specific nuclear receptor (NR2E3) and preparation of a radioligand.
Wolkenberg SE; Zhao Z; Kapitskaya M; Webber AL; Petrukhin K; Tang YS; Dean DC; Hartman GD; Lindsley CW
Bioorg Med Chem Lett; 2006 Oct; 16(19):5001-4. PubMed ID: 16879962
[TBL] [Abstract][Full Text] [Related]
46. Mutations in the DNA-binding domain of NR2E3 affect in vivo dimerization and interaction with CRX.
Roduit R; Escher P; Schorderet DF
PLoS One; 2009 Oct; 4(10):e7379. PubMed ID: 19823680
[TBL] [Abstract][Full Text] [Related]
47. Salicylates are interference compounds in TR-FRET assays.
Hanley RP; Horvath S; An J; Hof F; Wulff JE
Bioorg Med Chem Lett; 2016 Feb; 26(3):973-977. PubMed ID: 26733476
[TBL] [Abstract][Full Text] [Related]
48. Identification of pregnane X receptor ligands using time-resolved fluorescence resonance energy transfer and quantitative high-throughput screening.
Shukla SJ; Nguyen DT; Macarthur R; Simeonov A; Frazee WJ; Hallis TM; Marks BD; Singh U; Eliason HC; Printen J; Austin CP; Inglese J; Auld DS
Assay Drug Dev Technol; 2009 Apr; 7(2):143-69. PubMed ID: 19505231
[TBL] [Abstract][Full Text] [Related]
49. Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal.
Zielinski T; Reichman M; Donover PS; Lowery RG
Assay Drug Dev Technol; 2016 May; 14(4):240-51. PubMed ID: 27136323
[TBL] [Abstract][Full Text] [Related]
50. Expression of photoreceptor-specific nuclear receptor NR2E3 in rod photoreceptors of fetal human retina.
Bumsted O'Brien KM; Cheng H; Jiang Y; Schulte D; Swaroop A; Hendrickson AE
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2807-12. PubMed ID: 15277507
[TBL] [Abstract][Full Text] [Related]
51. (Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
Lieber S; Scheer F; Meissner W; Naruhn S; Adhikary T; Müller-Brüsselbach S; Diederich WE; Müller R
J Med Chem; 2012 Mar; 55(6):2858-68. PubMed ID: 22369181
[TBL] [Abstract][Full Text] [Related]
52. Validation of a High-Throughput Calcium Mobilization Assay for the Human Trace Amine-Associated Receptor 1.
Decker AM; Mathews KM; Blough BE; Gilmour BP
SLAS Discov; 2021 Jan; 26(1):140-150. PubMed ID: 32734809
[TBL] [Abstract][Full Text] [Related]
53. High Throughput Screening Assay to Identify Modulators of IL-17 Expression.
Boudjelal M; Ruiz-Avendano AM; Colmenarejo G; Senar-Sancho SA; Barnes A; Harrison SA
Comb Chem High Throughput Screen; 2017; 20(9):804-819. PubMed ID: 28571538
[TBL] [Abstract][Full Text] [Related]
54. Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4.
Schulze J; Moosmayer D; Weiske J; Fernández-Montalván A; Herbst C; Jung M; Haendler B; Bader B
J Biomol Screen; 2015 Feb; 20(2):180-9. PubMed ID: 25266565
[TBL] [Abstract][Full Text] [Related]
55. A dual estrogen receptor TR-FRET assay for simultaneous measurement of steroid site binding and coactivator recruitment.
Hilal T; Puetter V; Otto C; Parczyk K; Bader B
J Biomol Screen; 2010 Mar; 15(3):268-78. PubMed ID: 20150592
[TBL] [Abstract][Full Text] [Related]
56. NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP).
Schorderet DF; Escher P
Hum Mutat; 2009 Nov; 30(11):1475-85. PubMed ID: 19718767
[TBL] [Abstract][Full Text] [Related]
57. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
Newman M; Josiah S
J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
[TBL] [Abstract][Full Text] [Related]
58. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
[TBL] [Abstract][Full Text] [Related]
59. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay.
Pantel J; Williams SY; Mi D; Sebag J; Corbin JD; Weaver CD; Cone RD
Eur J Pharmacol; 2011 Jun; 660(1):139-47. PubMed ID: 21296065
[TBL] [Abstract][Full Text] [Related]
60. Fluorescence resonance energy transfer assay for high-throughput screening of ADAMTS1 inhibitors.
Peng J; Gong L; Si K; Bai X; Du G
Molecules; 2011 Dec; 16(12):10709-21. PubMed ID: 22186957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
